Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness

Ezz el din S Ibrahim; Stuart A McLellan; Timothy S Walsh

Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness

Ezz el din S Ibrahim, Stuart A McLellan, Timothy S Walsh

Research output: Contribution to journal › Article › peer-review

Abstract

To measure red blood cell 2,3-diphosphoglycerate (RBC 2,3-DPG) concentrations in early critical illness; to investigate factors associated with high or low RBC 2,3-DPG levels; to calculate in vivo P50 in patients with early critical illness; and to explore the relationship between RBC 2,3-DPG and intensive care mortality.

Original language	English
Pages (from-to)	2247-52
Number of pages	6
Journal	Critical Care Medicine
Volume	33
Issue number	10
Publication status	Published - 2005

Cite this

@article{d0b6457ff4f24d699d381687e568e318,

title = "Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness",

abstract = "To measure red blood cell 2,3-diphosphoglycerate (RBC 2,3-DPG) concentrations in early critical illness; to investigate factors associated with high or low RBC 2,3-DPG levels; to calculate in vivo P50 in patients with early critical illness; and to explore the relationship between RBC 2,3-DPG and intensive care mortality.",

author = "Ibrahim, {Ezz el din S} and McLellan, {Stuart A} and Walsh, {Timothy S}",

year = "2005",

language = "English",

volume = "33",

pages = "2247--52",

journal = "Critical Care Medicine",

issn = "0090-3493",

publisher = "Lippincott Williams & Wilkins",

number = "10",

}

TY - JOUR

T1 - Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness

AU - Ibrahim, Ezz el din S

AU - McLellan, Stuart A

AU - Walsh, Timothy S

PY - 2005

Y1 - 2005

N2 - To measure red blood cell 2,3-diphosphoglycerate (RBC 2,3-DPG) concentrations in early critical illness; to investigate factors associated with high or low RBC 2,3-DPG levels; to calculate in vivo P50 in patients with early critical illness; and to explore the relationship between RBC 2,3-DPG and intensive care mortality.

AB - To measure red blood cell 2,3-diphosphoglycerate (RBC 2,3-DPG) concentrations in early critical illness; to investigate factors associated with high or low RBC 2,3-DPG levels; to calculate in vivo P50 in patients with early critical illness; and to explore the relationship between RBC 2,3-DPG and intensive care mortality.

M3 - Article

C2 - 16215378

SN - 0090-3493

VL - 33

SP - 2247

EP - 2252

JO - Critical Care Medicine

JF - Critical Care Medicine

IS - 10

ER -

Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness

Abstract

Fingerprint

Cite this